{"disease":{"id":"myotonic-dystrophy-type-2","name":"myotonic dystrophy type 2"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04907162","title":"Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"LMU Klinikum","has_results":false},{"nct_id":"NCT03603171","title":"Clinical Outcome Measures in Myotonic Dystrophy Type 2","phase":"","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Prof. Dr. Benedikt Schoser","has_results":false},{"nct_id":"NCT03211923","title":"Muscle Relaxation in Myopathies With Positive Muscle Phenomena","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT03867435","title":"Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)","phase":"","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT04700046","title":"Study to Investigate the Efficacy and Safety of Mexiletine in Patients With Myotonic Dystrophy Type 1 and Type 2","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Lupin Ltd.","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}